nach oben

Cancer Causes & Control

Erschienen in:

01.09.2015 | Review article

Alcohol consumption and liver cancer risk: a meta-analysis

verfasst von: Shu-Chun Chuang, Yuan-Chin Amy Lee, Guo-Jie Wu, Kurt Straif, Mia Hashibe

Erschienen in: Cancer Causes & Control | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Alcohol is a confirmed risk factor of liver cancer. Yet, its dose–response function and synergistic effects with other risk factors remain unclear.

Methods

We performed a meta-analysis on publications up to May 2014. A total of 112 publications were identified. The meta-relative risk (mRR) and the dose–response trend were calculated. Tests for heterogeneity, publication bias, and sensitivity analyses were performed. The synergy index (SI) was recorded or calculated, whenever possible.

Results

Compared to individuals who never drank or drank at very low frequencies, the mRR for ever drinkers was 1.29 (95 % confidence interval, CI 1.16–1.42) and 1.46 (95 % CI 1.27–1.65) for case–control studies, and 1.07 (95 % CI 0.87–1.27) for cohort studies. Being a current drinker was associated with an increased liver cancer risk in case–control studies (mRR = 1.55, 95 % CI 0.38–2.73), but not in cohort studies (mRR = 0.86, 95 % CI 0.74–0.97). The dose–response relation between alcohol and liver cancer was apparent with RR = 1.08 (95 % CI 1.04–1.11) for 12 g/day (~1 drink), 1.54 (95 % CI 1.36–1.74) for 50 g/day, 2.14 (95 % CI 1.74–2.62) for 75 g/day, 3.21 (95 % CI 2.34–4.40) for 100 g/day, and 5.20 (95 % CI 3.25–8.29) for 125 g/day of alcohol consumption. There were synergistic effects of alcohol consumption with hepatitis (S = 2.14, 95 % CI 1.31–2.98) and with diabetes (S = 3.57, 95 % CI 2.29–4.84) on the risk of liver cancer, although this may be subject to publication bias.

Conclusion

Overall, one alcoholic drink per day (~12 g/day) may be associated with a 1.1 times higher liver cancer risk. Further studies on the synergistic effects of alcohol consumption and other major risk factors are warranted.

Nur mit Berechtigung zugänglich

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon. Available from: http://globocan.iarc.fr. Accessed 22 June 2015

Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38(10 Suppl 3):S158–S168PubMed

IARC Working Group (2012) Biological agents. IARC Monogr Eval Carcinogen Risks Humans 100B:93–168

Schottenfeld D, Beebe-Dimmer JL, Buffler PA, Omenn GS (2013) Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. Annu Rev Public Health 34:97–117PubMed

Liu Y, Chang CC, Marsh GM, Wu F (2012) Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer 48(14):2125–2136PubMedCentralPubMed

Chuang SC, La Vecchia C, Boffetta P (2009) Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286(1):9–14PubMed

IARC Working Group (1988) Alcohol drinking. IARC Monogr Eval Carcinogen Risks Humans 44:1–416

El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365(12):1118–1127PubMed

Donato F, Gelatti U, Limina RM, Fattovich G (2006) Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 25(27):3756–3770PubMed

10.

Testino G (2011) The burden of cancer attributable to alcohol consumption. Maedica (Buchar) 6(4):313–320

11.

IARC Working Group (2012) Personal habits and indoor combustions. IARC Monogr Eval Carcinogen Risks Humans 100E:373–499

12.

Stickel F, Schuppan D, Hahn EG, Seitz HK (2002) Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51(1):132–139PubMedCentralPubMed

13.

Singal AK, Anand BS (2007) Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol 41(8):761–772PubMed

14.

Turati F, Galeone C, Rota M et al (2014) Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol 25(8):1526–1535PubMed

15.

Wraith D, Mengersen K (2008) A Bayesian approach to assess interaction between known risk factors: the risk of lung cancer from exposure to asbestos and smoking. Stat Methods Med Res 17(2):171–189PubMed

16.

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560PubMedCentralPubMed

17.

Rota M, Bellocco R, Scotti L et al (2010) Random-effects meta-regression models for studying nonlinear dose–response relationship, with an application to alcohol and esophageal squamous cell carcinoma. Stat Med 29(26):2679–2687PubMed

18.

Bagnardi V, Zambon A, Quatto P, Corrao G (2004) Flexible meta-regression functions for modeling aggregate dose–response data, with an application to alcohol and mortality. Am J Epidemiol 159(11):1077–1086PubMed

19.

Berlin JA, Longnecker MP, Greenland S (1993) Meta-analysis of epidemiologic dose–response data. Epidemiology 4(3):218–228PubMed

20.

Sorensen HT, Friis S, Olsen JH et al (1998) Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28(4):921–925PubMed

21.

Zaridze D, Brennan P, Boreham J et al (2009) Alcohol and cause-specific mortality in Russia: a retrospective case–control study of 48,557 adult deaths. Lancet 373(9682):2201–2214PubMedCentralPubMed

22.

Kato I, Tominaga S, Ikari A (1992) The risk and predictive factors for developing liver cancer among patients with decompensated liver cirrhosis. Jpn J Clin Oncol 22(4):278–285PubMed

23.

Choi SY, Kahyo H (1991) Effect of cigarette smoking and alcohol consumption in the etiology of cancers of the digestive tract. Int J Cancer 49(3):381–386PubMed

24.

Heckley GA, Jarl J, Asamoah BO, Gerdtham U (2011) How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer 11:446PubMedCentralPubMed

25.

International Agency for Research on Cancer (2007) Tobacco control: reversal of risk after quitting smoking. In IARC Handbooks of cancer prevention, vol 11. Lyon, IARC, pp 1–366

26.

Corrao G, Bagnardi V, Zambon A, La VC (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38(5):613–619PubMed

27.

Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85(11):1700–1705PubMedCentralPubMed

28.

Corrao G, Bagnardi V, Zambon A, Arico S (1999) Exploring the dose–response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction 94(10):1551–1573PubMed

29.

Bradley KA, Badrinath S, Bush K, Boyd-Wickizer J, Anawalt B (1998) Medical risks for women who drink alcohol. J Gen Intern Med 13(9):627–639PubMedCentralPubMed

30.

Baraona E, Abittan CS, Dohmen K et al (2001) Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 25(4):502–507PubMed

31.

Loomba R, Yang HI, Su J, Brenner D, Iloeje U, Chen CJ (2010) Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin Gastroenterol Hepatol 8(10):891–898PubMed

32.

London WT, McGlynn KA (2006) Liver cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 763–786

33.

Bulatao-Jayme J, Almero EM, Castro MC, Jardeleza MT, Salamat LA (1982) A case–control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 11(2):112–119PubMed

34.

Omer RE, Verhoef L, Van’t VP et al (2001) Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case–control study in Sudan. Cancer Causes Control 12(1):23–32PubMed

35.

Omer RE, Kuijsten A, Kadaru AM et al (2004) Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma. Nutr Cancer 48(1):15–21PubMed

36.

Lu SN, Lin TM, Chen CJ et al (1988) A case–control study of primary hepatocellular carcinoma in Taiwan. Cancer 62(9):2051–2055PubMed

37.

Ross RK, Yuan JM, Yu MC et al (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339(8799):943–946PubMed

38.

Zhang JY, Wang X, Han SG, Zhuang H (1998) A case–control study of risk factors for hepatocellular carcinoma in Henan, China. Am J Trop Med Hyg 59(6):947–951PubMed

39.

Xu L, Qian G, Tang L, Su J, Wang JS (2010) Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China. J Hepatol 53(4):671–676PubMed

40.

Chen CJ, Liang KY, Chang AS et al (1991) Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 13(3):398–406PubMed

41.

Chen CJ, Wang LY, Lu SN et al (1996) Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 24(1):38–42PubMed

42.

Wu HC, Wang Q, Yang HI et al (2009) Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomark Prev 18(3):846–853

43.

Srivatanakul P, Parkin DM, Khlat M et al (1991) Liver cancer in Thailand. II. A case–control study of hepatocellular carcinoma. Int J Cancer 48(3):329–332PubMed

44.

Asim M, Sarma MP, Thayumanavan L, Kar P (2011) Role of aflatoxin B1 as a risk for primary liver cancer in north Indian population. Clin Biochem 44(14–15):1235–1240PubMed

45.

WHO (2014) Global status report on alcohol and health. World Health Organization, Geneva

46.

Kono S, Ikeda M, Tokudome S, Nishizumi M, Kuratsune M (1987) Cigarette smoking, alcohol and cancer mortality: a cohort study of male Japanese physicians. Jpn J Cancer Res 78(12):1323–1328PubMed

47.

Kono S, Ikeda M, Tokudome S, Yoshimura T, Nishizumi M, Kuratsune M (1985) Alcohol and cancer in male Japanese physicians. J Cancer Res Clin Oncol 109(1):82–85PubMed

48.

Kono S, Ikeda M, Tokudome S, Nishizumi M, Kuratsune M (1986) Alcohol and mortality: a cohort study of male Japanese physicians. Int J Epidemiol 15(4):527–532PubMed

49.

Shibata A, Fukuda K, Toshima H, Tashiro H, Hirohata T (1990) The role of cigarette smoking and drinking in the development of liver cancer: 28 years of observations on male cohort members in a farming and fishing area. Cancer Detect Prev 14(6):617–623PubMed

50.

Shibata A, Hirohata T, Toshima H, Tashiro H (1986) The role of drinking and cigarette smoking in the excess deaths from liver cancer. Jpn J Cancer Res 77(3):287–295PubMed

51.

Chang CC, Yu MW, Lu CF, Yang CS, Chen CJ (1994) A nested case–control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. J Med Virol 43(3):276–280PubMed

52.

Goodman MT, Moriwaki H, Vaeth M, Akiba S, Hayabuchi H, Mabuchi K (1995) Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology 6(1):36–41PubMed

53.

London WT, Evans AA, McGlynn K et al (1995) Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 38(3–4):155–161PubMed

54.

Sakoda LC, Graubard BI, Evans AA et al (2005) Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer 115(4):618–624PubMed

55.

Yu MW, Hsu FC, Sheen IS et al (1997) Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145(11):1039–1047PubMed

56.

Yuan JM, Ross RK, Gao YT, Henderson BE, Yu MC (1997) Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ 314(7073):18–23PubMedCentralPubMed

57.

Yu MW, Chiu YH, Chiang YC et al (1999) Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 149(7):621–629PubMed

58.

Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ (1999) Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol 150(4):367–374PubMed

59.

Yu MW, Pai CI, Yang SY et al (2000) Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut 47(5):703–709PubMedCentralPubMed

60.

Mori M, Hara M, Wada I et al (2000) Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 151(2):131–139PubMed

61.

Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomark Prev 11(4):369–376

62.

Jee SH, Ohrr H, Sull JW, Samet JM (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96(24):1851–1856PubMed

63.

Nakaya N, Tsubono Y, Kuriyama S et al (2005) Alcohol consumption and the risk of cancer in Japanese men: the Miyagi cohort study. Eur J Cancer Prev 14(2):169–174PubMed

64.

Ozasa K (2007) Alcohol use and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev 8(Suppl):81–88PubMed

65.

Ogimoto I, Shibata A, Kurozawa Y et al (2004) Risk of death due to hepatocellular carcinoma among drinkers and ex-drinkers. Univariate analysis of JACC study data. Kurume Med J 51(1):59–70PubMed

66.

Allen NE, Beral V, Casabonne D et al (2009) Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101(5):296–305PubMed

67.

Wang CS, Yao WJ, Chang TT, Wang ST, Chou P (2009) The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomark Prev 18(7):2054–2060

68.

Kim MK, Ko MJ, Han JT (2010) Alcohol consumption and mortality from all-cause and cancers among 1.34 million Koreans: the results from the Korea national health insurance corporation’s health examinee cohort in 2000. Cancer Causes Control 21(12):2295–2302PubMed

69.

Yang HI, Lu SN, Liaw YF et al (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347(3):168–174PubMed

70.

Sun CA, Wu DM, Lin CC et al (2003) Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 157(8):674–682PubMed

71.

Wang LY, You SL, Lu SN et al (2003) Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 14(3):241–250PubMed

72.

Chen CJ, Yang HI, Su J et al (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295(1):65–73PubMed

73.

Chen CL, Yang HI, Yang WS et al (2008) Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135(1):111–121PubMed

74.

Yang HI, Yeh SH, Chen PJ et al (2008) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100(16):1134–1143PubMedCentralPubMed

75.

Chen JD, Yang HI, Iloeje UH et al (2010) Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 138(5):1747–1754PubMed

76.

Loomba R, Yang HI, Su J et al (2013) Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol 177(4):333–342PubMedCentralPubMed

77.

Yi SW, Sull JW, Linton JA, Nam CM, Ohrr H (2010) Alcohol consumption and digestive cancer mortality in Koreans: the Kangwha Cohort Study. J Epidemiol 20(3):204–211PubMedCentralPubMed

78.

Koh WP, Robien K, Wang R, Govindarajan S, Yuan JM, Yu MC (2011) Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer 105(9):1430–1435PubMedCentralPubMed

79.

Shimazu T, Sasazuki S, Wakai K et al (2011) Alcohol drinking and primary liver cancer: a pooled analysis of four Japanese cohort studies. Int J Cancer 130(11):2645–2653PubMed

80.

Joshi S, Song YM, Kim TH, Cho SI (2008) Socio-economic status and the risk of liver cancer mortality: a prospective study in Korean men. Public Health 122(11):1144–1151PubMed

81.

Jung EJ, Shin A, Park SK et al (2012) Alcohol consumption and mortality in the Korean Multi-Center Cancer Cohort Study. J Prev Med Public Health 45(5):301–308PubMedCentralPubMed

82.

Yang L, Zhou M, Sherliker P et al (2012) Alcohol drinking and overall and cause-specific mortality in China: nationally representative prospective study of 220,000 men with 15 years of follow-up. Int J Epidemiol 41(4):1101–1113PubMed

83.

Shen C, Schooling CM, Chan WM, Xu L, Lee SY, Lam TH (2013) Alcohol intake and death from cancer in a prospective Chinese elderly cohort study in Hong Kong. J Epidemiol Commun Health 67(10):813–820

84.

Persson EC, Schwartz LM, Park Y et al (2013) Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomark Prev 22(3):415–421

85.

Michikawa T, Inoue M, Sawada N et al (2012) Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II. Prev Med 55(2):137–143PubMed

86.

Stemhagen A, Slade J, Altman R, Bill J (1983) Occupational risk factors and liver cancer. A retrospective case–control study of primary liver cancer in New Jersey. Am J Epidemiol 117(4):443–454PubMed

87.

Yu MC, Mack T, Hanisch R, Peters RL, Henderson BE, Pike MC (1983) Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res 43(12 Pt 1):6077–6079PubMed

88.

Austin H, Delzell E, Grufferman S et al (1986) A case–control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res 46(2):962–966PubMed

89.

Tsukuma H, Hiyama T, Oshima A et al (1990) A case–control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 45(2):231–236PubMed

90.

Caporaso N, Romano M, Marmo R et al (1991) Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 12(3):367–371PubMed

91.

Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ (1991) Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 51(20):5621–5625PubMed

92.

Chen CJ, Liang KY, Chang AS et al (1991) Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 13(3):398–406PubMed

93.

Mohamed AE, Kew MC, Groeneveld HT (1992) Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer 51(4):537–541PubMed

94.

Simonetti RG, Camma C, Fiorello F et al (1992) Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case–control study. Ann Intern Med 116(2):97–102PubMed

95.

Tanaka K, Hirohata T, Takeshita S et al (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case–control study in Fukuoka, Japan. Int J Cancer 51(4):509–514PubMed

96.

Tanaka K, Hirohata T, Takeshita S (1988) Blood transfusion, alcohol consumption, and cigarette smoking in causation of hepatocellular carcinoma: a case–control study in Fukuoka, Japan. Jpn J Cancer Res 79(10):1075–1082PubMed

97.

Cordier S, Le TB, Verger P et al (1993) Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam. Int J Cancer 55(2):196–201PubMed

98.

Fukuda K, Shibata A, Hirohata I, Tanikawa K, Yamaguchi G, Ishii M (1993) A hospital-based case–control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan. Jpn J Cancer Res 84(7):708–714PubMed

99.

Yamaguchi G (1993) Hepatocellular carcinoma and its risk factors—their annual changes and effects on the age at onset. Kurume Med J 40(1):33–40PubMed

100.

Arico S, Corrao G, Torchio P et al (1994) A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. A case–control study. Eur J Epidemiol 10(3):251–257PubMed

101.

Peters M, Wellek S, Dienes HP et al (1994) Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Z Gastroenterol 32(3):146–151PubMed

102.

Pyong SJ, Tsukuma H, Hiyama T (1994) Case–control study of hepatocellular carcinoma among Koreans living in Osaka, Japan. Jpn J Cancer Res 85(7):674–679PubMed

103.

Chiba T, Matsuzaki Y, Abei M et al (1996) Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis. J Gastroenterol 31(4):552–558PubMed

104.

Murata M, Takayama K, Choi BC, Pak AW (1996) A nested case–control study on alcohol drinking, tobacco smoking, and cancer. Cancer Detect Prev 20(6):557–565PubMed

105.

Shin HR, Lee CU, Park HJ et al (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case–control study in Pusan, Korea. Int J Epidemiol 25(5):933–940PubMed

106.

Wang LY, Hatch M, Chen CJ et al (1996) Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 67(5):620–625PubMed

107.

Chen CJ, Wang LY, Lu SN et al (1996) Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 24(1):38–42PubMed

108.

Wu HC, Wang Q, Wang LW et al (2007) Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 28(5):995–999PubMed

109.

Wu HC, Wang Q, Yang HI et al (2009) Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomark Prev 18(3):846–853

110.

Braga C, La Vecchia C, Negri E, Franceschi S (1997) Attributable risks for hepatocellular carcinoma in northern Italy. Eur J Cancer 33(4):629–634PubMed

111.

La Vecchia C, Negri E, Decarli A, D’Avanzo B, Franceschi S (1988) Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 42(6):872–876PubMed

112.

La Vecchia C, Negri E, D’Avanzo B, Boyle P, Franceschi S (1990) Medical history and primary liver cancer. Cancer Res 50(19):6274–6277

113.

La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73(2):204–207

114.

La Vecchia C, Negri E, Cavalieri DL, Franceschi S (1998) Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 7(4):315–320

115.

Shibata A, Fukuda K, Nishiyori A, Ogimoto I, Sakata R, Tanikawa K (1998) A case–control study on male hepatocellular carcinoma based on hospital and community controls. J Epidemiol 8(1):1–5PubMed

116.

Wang LY, Chen CJ, Zhang YJ et al (1998) 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol 147(3):315–323PubMed

117.

Koide T, Ohno T, Huang XE et al (2000) HBV/HCV infection, alcohol, tobacco and genetic polymorphisms for hepatocellular carcinoma in Nagoya, Japan. Asian Pac J Cancer Prev 1(3):237–243PubMed

118.

Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO (2000) Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 92(13):1096–1099PubMed

119.

Kuper H, Tzonou A, Kaklamani E et al (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85(4):498–502PubMed

120.

Kuper H, Lagiou P, Mucci LA, Tamimi R, Benetou V, Trichopoulos D (2001) Risk factors for cholangiocarcinoma in a low risk Caucasian population. Soz Praventivmed 46(3):182–185PubMed

121.

Takeshita T, Yang X, Inoue Y, Sato S, Morimoto K (2000) Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese. Cancer Lett 149(1–2):69–76PubMed

122.

Hassan MM, Hwang LY, Hatten CJ et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36(5):1206–1213PubMed

123.

Yu SZ, Huang XE, Koide T et al (2002) Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China. Jpn J Cancer Res 93(12):1287–1292PubMed

124.

Huang YS, Chern HD, Wu JC et al (2003) Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol 98(6):1417–1422PubMed

125.

Matsuo M (2003) Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case–control study. Kurume Med J 50(3–4):91–98PubMed

126.

Munaka M, Kohshi K, Kawamoto T et al (2003) Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol 129(6):355–360PubMed

127.

Tsai JF, Jeng JE, Chuang LY et al (2003) Habitual betel quid chewing as a risk factor for cirrhosis: a case–control study. Medicine (Baltimore) 82(5):365–372

128.

Yuan JM, Govindarajan S, Arakawa K, Yu MC (2004) Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 101(5):1009–1017PubMed

129.

Yu MC, Tong MJ, Govindarajan S, Henderson BE (1991) Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 83(24):1820–1826PubMed

130.

Yu MC, Yuan JM, Lu SC (2008) Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol 23(Suppl 1):S92–S97PubMedCentralPubMed

131.

Gelatti U, Covolo L, Talamini R et al (2005) N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case–control study. Int J Cancer 115(2):301–306PubMed

132.

Covolo L, Gelatti U, Talamini R et al (2005) Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy). Cancer Causes Control 16(7):831–838PubMed

133.

Gelatti U, Covolo L, Franceschini M et al (2005) Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case–control study. J Hepatol 42(4):528–534PubMed

134.

Donato F, Tagger A, Chiesa R et al (1997) Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case–control study in Italy. Brescia HCC Study. Hepatology 26(3):579–584PubMed

135.

Donato F, Gelatti U, Chiesa R et al (1999) A case–control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study. Cancer Causes Control 10(5):417–421PubMed

136.

Tagger A, Donato F, Ribero ML et al (1999) Case–control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer 81(5):695–699PubMed

137.

Donato F, Tagger A, Gelatti U et al (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155(4):323–331PubMed

138.

Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42(2):218–224PubMed

139.

Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC (2005) Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenterol 11(2):289–292PubMedCentralPubMed

140.

Zhu ZZ, Cong WM, Liu SF et al (2005) A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett 229(1):77–83PubMed

141.

Fukushima W, Tanaka T, Ohfuji S et al (2006) Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection? Hepatol Res 34(3):141–149PubMed

142.

Sakamoto T, Hara M, Higaki Y et al (2006) Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population. Int J Cancer 118(6):1501–1507PubMed

143.

Imaizumi T, Higaki Y, Hara M et al (2009) Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population. Carcinogenesis 30(10):1729–1734PubMed

144.

Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M (2006) Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. Int J Mol Med 17(5):827–832PubMed

145.

Yuan JM, Gao YT, Ong CN, Ross RK, Yu MC (2006) Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma. J Natl Cancer Inst 98(7):482–490PubMed

146.

Kumar M, Kumar R, Hissar SS et al (2007) Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case–control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 22(7):1104–1111PubMed

147.

Polesel J, Talamini R, Montella M et al (2007) Nutrients intake and the risk of hepatocellular carcinoma in Italy. Eur J Cancer 43(16):2381–2387PubMed

148.

Franceschi S, Montella M, Polesel J et al (2006) Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomark Prev 15(4):683–689

149.

Talamini R, Polesel J, Montella M et al (2006) Food groups and risk of hepatocellular carcinoma: a multicenter case–control study in Italy. Int J Cancer 119(12):2916–2921PubMed

150.

Montella M, Polesel J, La Vecchia C et al (2007) Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 120(7):1555–1559PubMed

151.

Ferrand JF, Cenee S, Laurent-Puig P et al (2008) Hepatocellular carcinoma and occupation in men: a case–control study. J Occup Environ Med 50(2):212–220PubMed

152.

Yoon YJ, Chang HY, Ahn SH et al (2008) MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 29(6):1192–1196PubMed

153.

Benedetti A, Parent ME, Siemiatycki J (2009) Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case–control study in Montreal. Cancer Detect Prev 32(5–6):352–362PubMed

154.

Hassan MM, Spitz MR, Thomas MB et al (2009) The association of family history of liver cancer with hepatocellular carcinoma: a case–control study in the United States. J Hepatol 50(2):334–341PubMedCentralPubMed

155.

Hassan MM, Spitz MR, Thomas MB et al (2008) Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case–control study. Int J Cancer 123(8):1883–1891PubMedCentralPubMed

156.

Hassan MM, Kaseb A, Li D et al (2009) Association between hypothyroidism and hepatocellular carcinoma: a case–control study in the United States. Hepatology 49(5):1563–1570PubMedCentralPubMed

157.

Hassan MM, Curley SA, Li D et al (2010) Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 116(8):1938–1946PubMedCentralPubMed

158.

Jeng JE, Tsai HR, Chuang LY et al (2009) Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore) 88(6):349–357

159.

Balbi M, Donadon V, Ghersetti M et al (2010) Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy. Int J Environ Res Public Health 7(4):1366–1378PubMedCentralPubMed

160.

Donadon V, Balbi M, Casarin P, Vario A, Alberti A (2008) Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. World J Gastroenterol 14(37):5695–5700PubMedCentralPubMed

161.

Yun EH, Lim MK, Oh JK et al (2010) Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea. Br J Cancer 103(5):741–746PubMedCentralPubMed

162.

Asim M, Khan LA, Husain SA et al (2010) Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Dis Markers 28(6):369–376PubMedCentralPubMed

163.

Li Y, Chang SC, Goldstein BY et al (2011) Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol 35(4):362–368PubMedCentralPubMed

164.

Mu LN, Cao W, Zhang ZF et al (2007) Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control 18(6):665–675PubMedCentralPubMed

165.

Liu J, Yang Y, Zhang H et al (2011) Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case–control analysis. Cancer 117(18):4247–4256PubMed

166.

Ohishi W, Fujiwara S, Cologne JB et al (2011) Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma. Hepatology 53(4):1237–1245PubMed

167.

Sharp GB, Lagarde F, Mizuno T et al (2005) Relationship of hepatocellular carcinoma to soya food consumption: a cohort-based, case–control study in Japan. Int J Cancer 115(2):290–295PubMed

168.

Ohishi W, Fujiwara S, Cologne JB et al (2008) Risk factors for hepatocellular carcinoma in a Japanese population: a nested case–control study. Cancer Epidemiol Biomark Prev 17(4):846–854

169.

Trichopoulos D, Bamia C, Lagiou P et al (2011) Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case–control study. J Natl Cancer Inst 103(22):1686–1695PubMedCentralPubMed

170.

Ha NB, Ha NB, Ahmed A et al (2012) Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study. Cancer Causes Control 23(3):455–462PubMed

171.

Tanaka K, Hirohata T, Fukuda K, Shibata A, Tsukuma H, Hiyama T (1995) Risk factors for hepatocellular carcinoma among Japanese women. Cancer Causes Control 6(2):91–98PubMed

172.

Asim M, Sarma MP, Kar P (2013) Etiological and molecular profile of hepatocellular cancer from India. Int J Cancer 133(2):437–445PubMed

173.

Patil PS, Mohandas KM, Bhatia SJ, Mehta SA (2014) Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case–control study. Indian J Gastroenterol 33(1):12–18PubMed

174.

Kuske L, Mensen A, Mullhaupt B et al (2012) Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss Med Wkly 142:w13651PubMed

175.

Ikeda K, Saitoh S, Koida I et al (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18(1):47–53PubMed

176.

Tsukuma H, Hiyama T, Tanaka S et al (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328(25):1797–1801PubMed

177.

Benvegnu L, Fattovich G, Noventa F et al (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74(9):2442–2448PubMed

178.

Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G (2000) Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer 89(1):53–59PubMed

179.

Ishikawa T, Ichida T, Yamagiwa S et al (2001) High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis. J Gastroenterol Hepatol 16(11):1274–1281PubMed

180.

Iwasaki Y, Takaguchi K, Ikeda H et al (2004) Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy. Liver Int 24(6):603–610PubMed

181.

Ohata K, Hamasaki K, Toriyama K, Ishikawa H, Nakao K, Eguchi K (2004) High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 19(6):670–675PubMed

182.

Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU (2007) Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 46(5):1350–1356PubMed

183.

Ikeda K, Marusawa H, Osaki Y et al (2007) Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med 146(9):649–656PubMed

184.

Chuma M, Hige S, Nakanishi M et al (2008) 8-Hydroxy-2′-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 23(9):1431–1436PubMed

185.

Stroffolini T, Almasio PL, Persico M et al (2008) Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis. Am J Gastroenterol 103(8):1966–1972PubMed

186.

Cavazza A, Caballeria L, Floreani A et al (2009) Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. Hepatology 50(4):1162–1168PubMed

187.

Ikeda K, Kobayashi M, Someya T et al (2009) Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepat 16(6):437–443PubMed

188.

Romeo R, Del NE, Rumi M et al (2009) A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 136(5):1629–1638PubMed

189.

Ohki T, Tateishi R, Goto E et al (2010) Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors. J Viral Hepat 17(2):91–97PubMed

190.

Di Martino V, Crouzet J, Hillon P, Thevenot T, Minello A, Monnet E (2011) Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis. J Viral Hepat 18(7):493–505PubMed

191.

Takahashi H, Mizuta T, Eguchi Y et al (2011) Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C. J Gastroenterol 46(6):790–798PubMed

Titel: Alcohol consumption and liver cancer risk: a meta-analysis
verfasst von: Shu-Chun Chuang
Yuan-Chin Amy Lee
Guo-Jie Wu
Kurt Straif
Mia Hashibe
Publikationsdatum: 01.09.2015
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 9/2015
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-015-0615-3

Springer Medizin

Alcohol consumption and liver cancer risk: a meta-analysis

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2015

Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort

Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies

Variable association of height with gastric cancer by anatomical subsite

Individual- and neighborhood-level education influences the effect of obesity on prostate cancer treatment failure after prostatectomy

5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Proportion of colon cancer attributable to lifestyle in a cohort of US women

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie